Do you have the same question? Follow this Question
Aug 27, 2025 - 09:06 AM
We’ve provided several answers to questions related to Uceris Rectal Foam (Budesonide) , see some other helpful Q&A related to this product.
Question: What is the protein binding percentage of budesonide in this product?
Answer: Budesonide has a protein binding percentage of 85-90%. This high protein binding ensures that the drug stays effective in the bloodstream for a longer duration, providing sustained therapeutic effects.
Question: What brands are available for the active ingredient in this product?
Answer: The active ingredient budesonide is available under brands such as Entocort and Pulmicort. Knowing alternative brands can help users understand their options and potential cost variations.
Question: What cautions should be considered when using this product?
Answer: Caution should be taken for patients with a history of infections, high blood pressure, or diabetes. These conditions can be affected by corticosteroid use, so careful monitoring and consultation with a healthcare provider are important.
Question: What are some common side effects of this product?
Answer: Common side effects include acne, dizziness, and nausea. Being aware of these potential side effects helps users monitor their response to the medication and seek medical advice if needed.
Question: Is a prescription required for this product?
Answer: Yes, a prescription is required to obtain this product. This ensures appropriate medical supervision and guidance, which is crucial for safe and effective treatment.
Question: What should pregnant individuals do before using this product?
Answer: Pregnant individuals should consult a doctor before using this product. This precaution ensures safety and helps assess any potential risks or necessary adjustments in treatment during pregnancy.
Question: What are the directions for using this product?
Answer: The directions for use are to administer twice daily for two weeks and then once daily for the next four weeks. This regimen helps manage and reduce inflammation effectively, providing relief from symptoms over a sustained period.
Question: How strong is each application of the foam?
Answer: Each application of the rectal foam contains 2 mg of budesonide. This dosage is specifically formulated to effectively reduce inflammation and manage symptoms of ulcerative colitis while minimizing systemic exposure.
Question: How should this product be administered?
Answer: This product should be administered rectally. The targeted administration directly addresses inflammation in the lower colon and rectum, making it an effective treatment for ulcerative colitis.
Question: What is the elimination half-life of budesonide in this product?
Answer: The elimination half-life of budesonide in this product is between 2 and 3.6 hours. This relatively short half-life allows for effective dosing and helps maintain consistent therapeutic levels in the targeted area, enhancing its effectiveness in treating symptoms.
Question: What is the formula of the active ingredient in this product?
Answer: The formula for budesonide, the active ingredient, is C25H34O6. This chemical composition helps budesonide effectively reduce inflammation in the colon and rectum, making it valuable for treating ulcerative colitis.
Question: What is the bioavailability of this product when administered rectally?
Answer: The bioavailability of this product when administered as a rectal foam is 10%. This low systemic absorption is beneficial as it targets the affected area directly, minimizing systemic side effects.
View all Uceris Rectal Foam (Budesonide) Questions & Answers
